Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 - April 2019
Greece introduced a 13-valent pneumococcal conjugate vaccine (PCV13) into the infant national immunization program in 2010 (3 + 1 schedule until June 2019). Since 2015, PCV13 has been recommended for adults aged 19-64 years with comorbidities and adults ≥65 years sequentially with 23-valent pneumoco...
Saved in:
Main Authors: | Adamantia Liapikou (Author), Athanasios Konstantinidis (Author), Vasiliki Kossyvaki (Author), John Skiadas (Author), Damianos Menegas (Author), Cristina Méndez (Author), Rohini Beavon (Author), Elizabeth Begier (Author), Bradford D. Gessner (Author), Haralampos Milionis (Author), Vasilios Tsimihodimos (Author), Gerasimos Baxevanos (Author), Theodora Argiriadou (Author), Chrysavgi Terrovitou (Author), Michael Toumbis (Author), The EGNATIA Study Group (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Community acquired pneumonia: a cost-of-illness analysis in Greece
by: Panagiota Naoum, et al.
Published: (2020) -
A cross-sectional vaccination coverage study in preschool children attending nurseries-kindergartens: Implications on economic crisis effect
by: Theano Georgakopoulou, et al.
Published: (2017) -
An overview of diagnosis and management of drug‐induced hypomagnesemia
by: George Liamis, et al.
Published: (2021) -
Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016-2018-The ECAPS study
by: Karin Hansen, et al.
Published: (2023) -
Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study
by: Claire von Mollendorf, et al.
Published: (2021)